 |
- Visfatin as an obesity-related cytokine with pro-inflammatory activities
- Monoclonal Antibody Pair
- Samples Tested
Citations for SK00121-06:
- Sanaa A. El-Benhawy, Nadia A. Abd El Moneim, Samia A. Ebeid
- "Serum Adipocytokines (Visfatin and Resistin): New Biomarkers of Breast Carcinogenesis"
Middle East Journal of Cancer; October 2015; 6(4): 253-265- Yaprak Engin-Ustun et al. "The effect of Ramadan fasting on sirtuin and visfatin levels" Interventional Medicine & Applied Science, Vol. 8 (1), pp. 14–19 (2016)
- Lateef N, Gul A, Shoaib M, Shirwany TAK. A Study of Serum Visfatin Levels in Obese and Non-Obese Primary Hypertensive Subjects. Isra Med J. 2017; 9(4): 233-37.
- Saadoun MM, Nosair NAE, Abdel-Azeez HA, Sharaf SM, Ahmed MH. Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease. J Gastrointestin Liver Dis. 2021 Sep 21;30(3):339-345
Citations for use SK00121-06:- Sanaa A. El-Benhawy, Nadia A. Abd El Moneim, Samia A. Ebeid
- "Serum Adipocytokines (Visfatin and Resistin): New Biomarkers of Breast Carcinogenesis"
Middle East Journal of Cancer; October 2015; 6(4): 253-265- Yaprak Engin-Ustun et al. "The effect of Ramadan fasting on sirtuin and visfatin levels" Interventional Medicine & Applied Science, Vol. 8 (1), pp. 14–19 (2016)
- Lateef N, Gul A, Shoaib M, Shirwany TAK. A Study of Serum Visfatin Levels in Obese and Non-Obese Primary Hypertensive Subjects. Isra Med J. 2017; 9(4): 233-37.
- Saadoun MM, Nosair NAE, Abdel-Azeez HA, Sharaf SM, Ahmed MH. Serum Visfatin as a Diagnostic Marker of Active Inflammatory Bowel Disease. J Gastrointestin Liver Dis. 2021 Sep 21;30(3):339-345
 
|
|
|